EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prevalence of female sexual dysfunction in Africa: A systematic review and meta-analysis

Andy-Muller Luzolo Nzinga, Véronique Feipel, Jeanne Bertuit

Journal of Medicine, Surgery, and Public Health · 2025-12 · 7 · 100202

DOI: 10.1016/j.glmedi.2025.100202 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Medicine, Surgery, and Public Health, 2025-12. Verfasst von Andy-Muller Luzolo Nzinga und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Female Sexual Dysfunction (FSD) is a multifactorial health issue influenced by physiological, psychological, and sociocultural factors. Despite a global prevalence of 10–63%, FSD is underrecognized in African contexts due to cultural taboos and limited healthcare access. This review and meta-analysis aim to assess FSD prevalence and risk factors across Africa, guiding culturally sensitive interventions, policies, and future research to improve women's sexual health. Following PRISMA guidelines, a systematic search was conducted in databases including PubMed, Embase, CINAHL, and African Journals Online (AJOL) for studies published between 2000 and 2023. Eligible studies reported FSD prevalence in African women aged 18 years and older. A meta-analysis of pooled prevalence was conducted using a random-effects model, with heterogeneity assessed using I² and Cochran’s Q tests. Thirteen studies involving 11,585 women from five African countries met the inclusion criteria. The pooled prevalence of FSD was 52.1% (95% CI: 45.7–58.4%), with significant heterogeneity (I² = 97.1%). Regional prevalence rates ranged from 39% in East Africa to 61% in West Africa (p=0.051). The pooled prevalence was 76.2% for desire disorder; 59.7%for arousal disorder; 73.7% for lubrication; 73.1% for orgasm disorder; 60.6% for sexual dissatisfaction and 51.6% for pain/dyspareunia. The diagnostic tool used influenced prevalence estimates, with the Female Sexual Function Index (FSFI) reporting lower rates (44%) compared to other tools (70%) (p

Zitieren

APA

Nzinga, A. L., Feipel, V., & Bertuit, J. (2025). Prevalence of female sexual dysfunction in Africa: A systematic review and meta-analysis. Journal of Medicine, Surgery, and Public Health, 7, 100202. https://doi.org/10.1016/j.glmedi.2025.100202

Vancouver

Nzinga AL, Feipel V, Bertuit J. Prevalence of female sexual dysfunction in Africa: A systematic review and meta-analysis. Journal of Medicine, Surgery, and Public Health. 2025;7:100202. doi:10.1016/j.glmedi.2025.100202

BibTeX
@article{Nzinga2025,
  author = {Nzinga, Andy-Muller Luzolo and Feipel, Véronique and Bertuit, Jeanne},
  title = {Prevalence of female sexual dysfunction in Africa: A systematic review and meta-analysis},
  journal = {Journal of Medicine, Surgery, and Public Health},
  year = {2025},
  volume = {7},
  pages = {100202},
  doi = {10.1016/j.glmedi.2025.100202}
}
Kostenlos starten →